The research partnership will include several American biotechnology companies and a pharmaceutical company based out of Tokyo.
UM professor of medicine Alan S. Cross, MD, and two assistant professors of medicine — Raphael Simon, PhD, and Sharon Tennant, PhD — will lead the Center for Vaccine Development project.
Even though healthcare-associated infections afflict millions of patients a year, there are no licensed vaccines currently available for any of the major HAIs.
“This is a response to a serious unmet need. We think this partnership has enormous potential,” said Dr. Cross. “We think we can make a significant dent in the effect these infections have in the U.S., and around the world.”
More articles on vaccines:
The first line of defense: 10 steps to boost influenza vaccinations among healthcare workers
Study: Most hospitals do not require staff to get flu shots
Researchers discover how to make flu vaccine more effective for high-risk cancer patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
